跳至主要内容
临床试验/NCT05427058
NCT05427058招募中不适用

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management: A Randomized Controlled Trial of Efficacy and Safety

University of Brawijaya2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
36
试验地点
2
主要终点
Morphine equivalent daily dose (MEDD)

研究概览

简要总结

This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer

详细描述

Superior hypogastric plexus block is a commonly used method for the management of pelvic and perineal pain due to cancer, this procedure uses a transdiscal approach at the level of the L5-S1 vertebrae by injecting 5 ml of 1% lidocaine + 10 ml of 96% alcohol and confirmed by C-arm.

Compared with the ganglion impar block procedure using a trans-sacrococcygeal approach by injecting 4 ml of 1% lidocaine + 6 ml of 96% alcohol and confirmed by C-arm. The aim of this study was to compare the efficacy and safety of the ganglion impar block procedure against the superior hypogastric plexus block which is commonly used in the management of pelvic and perineal pain due to cervical and endometrial cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Participant and Investigator masking:

The random order of the groups will be written on paper and hidden by using a sealed envelope with consecutive numbers. This envelope will be retained by personnel who are not involved in the care or evaluation of the patient, or the analysis of the data.

During the action, doctors and nurses are prohibited from communicating with participants regarding the actions given.

Outcomes assessor masking:

All data collection will be carried out by residents as research assistants who are trained for data collection. The assistant was not told what intervention was given to the patient, data collection was done directly by asking the patient without looking at the patient's status. The data that has been collected will be entered and processed by personnel outside the research team to ensure blinding.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
  • The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced constipation, gastrointestinal disturbances)
  • Patients with pelvic floor pain diagnosed by a (Fellow of Interventional Pain Practice) FIPP-certified pain specialist
  • Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
  • Numerical Rating Scale >4
  • >18 years old
  • Able and willing to sign an informed consent

排除标准

  • Refuse to be included in the research
  • Blood clotting disorders (including taking anticoagulant drugs)
  • Local infection in the area of action
  • Loss to follow up
  • Drop-out Criteria:
  • Loss to follow up
  • Intervention complications occur
  • Failed intervention

结局指标

主要结局

Morphine equivalent daily dose (MEDD)

时间窗: 3 Month

This is the dose that the patient takes regularly to relieve pain.

Numerical rating scale (NRS)

时间窗: 3 month

Used to measure pain relief with a value of 0-10 (0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-9 = severe pain, 10 = most severe pain). The average pain intensity felt by the patient in the last 1 week

Oswestry Disability Index (ODI)

时间窗: 3 Month

The Oswestry Disability Index is a measuring tool to evaluate the quality of life and the level of disability. In this study, we will use the Indonesian adaptation version. in a journal published by Phedy et al showed that the Indonesian version of the ODI retains the reliability, validity, and psychometric characteristics of the original ODI. There are 10 main questions with 6 assessment options from the lowest point of 0 and the highest point of 5. 0-20%: mild disability 21-40%: moderate disability, affecting activities can still be overcome 41-60%: severe disability, pain is a major problem and interferes with activities 61-80%: patients experience disturbances in major aspects of life requiring intervention 81-100%: the patient is confined to bed because of complaints

次要结局

  • Adverse effect(3 Month)

研究者

发起方
University of Brawijaya
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ristiawan Muji Laksono, MD

Principal Investigator

University of Brawijaya

研究点 (2)

Loading locations...

相似试验